Featured Studies

The National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (NIH) in Bethesda, Maryland is conducting a study for vasculitis. Researchers are inviting both volunteers who have the condition, and those who do not, to participate in this study. All study-related tests and procedures are provided at no cost to you.

Researchers at the National Cancer Institute (NCI) are conducting a clinical trial to study new imaging techniques for those with HCC. Pictures (Images) are taken with a positron emission tomography (PET) using a new investigational imaging radiotracer, 18 F-DCFPyL. Our research study focus is to see if this tracer will improve images taken of your liver to identify HCC tumors earlier in the disease process. We will also determine if we can see differences between treated tumors and the development of new tumors.

Researchers want to see if they can measure the amount of anti-cancer drug, Abemaciclib in a brain tumor and brain fluid after a patient has taken this drug for a few days. These findings can help explain how much drug gets into the brain and how drugs work to shrink high grade gliomas to improve outcomes for these patients.

Myelodysplastic syndromes (MDS) are disorders caused by abnormal blood cell production, potentially leading to low cell counts and increased susceptibility to clotting and infections. Past research suggests that inflammation may trigger these abnormalities, and this study seeks to further understand and improve treatment strategies for MDS by investigating the role of inflammation in bone marrow cell development.

Researchers from the National Cancer Institute at the NIH Clinical Center are currently looking for patients who have HER2-expressing endometrial cancer. The purpose of the study is to test two investigational study drugs, a vaccine that targets HER2 (AdHER2DC) and a drug that is expected to improve immune cell function (N-803). These study drugs will be used with pembrolizumab and lenvatinib which are FDA approved to treat endometrial cancer.